Wechalekar, Mihir D.
Zhao, Lin-Pierre https://orcid.org/0000-0001-5035-4470
Kutyna, Monika M.
Hong, Lih En
Li, Joule
Hung, Kevin https://orcid.org/0009-0001-9354-5864
Scott, Hamish S. https://orcid.org/0000-0002-5813-631X
Brown, Anna https://orcid.org/0000-0002-9023-0138
Hahn, Christopher C. https://orcid.org/0000-0001-5105-2554
Kassahn, Karin
Ladon, Dariusz
Yeung, David T.
Thomas, Daniel
Patnaik, Mrinal https://orcid.org/0000-0001-6998-662X
Proudman, Susanna
Ades, Lionel https://orcid.org/0000-0002-9020-8766
Shah, Mithun V. https://orcid.org/0000-0002-5359-336X
Kok, Chung H. https://orcid.org/0000-0002-3181-7852
Hiwase, Devendra K. https://orcid.org/0000-0002-6666-3056
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1195517)
Article History
Received: 9 May 2024
Revised: 27 June 2024
Accepted: 2 July 2024
First Online: 19 July 2024
Competing interests
: MVS: research funding to the institution from AbbVie, Celgene, MRKR Therapeutics and Astellas. DKH: membership on the advisory committees of AbbVie and Otsuka. All other authors have no competing interests to disclose.